CRNX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Crinetics Pharmaceuticals Inc

NASDAQ | CRNX

50.23

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 12, 2025)

$4.68B

Market Cap

-

P/E Ratio

-4.65

EPS

$56.15

52 Week High

$24.10

52 Week Low

HEALTHCARE

Sector

CRNX Chart

Recent Chart
Price Action

CRNX Technicals

Tags:

CRNX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1.7M
Total Revenue $1M
Cost Of Revenue $2.8M
Costof Goods And Services Sold $2.8M
Operating Income -$339M
Selling General And Administrative $100M
Research And Development $240M
Operating Expenses $337M
Investment Income Net -
Net Interest Income $41M
Interest Income $41M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.8M
Income Before Tax -$298M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$298M
Comprehensive Income Net Of Tax -
Ebit -$339M
Ebitda -$336M
Net Income -$298M

Revenue & Profitability

CRNX Financials

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1.7M
Total Revenue $1M
Cost Of Revenue $2.8M
Costof Goods And Services Sold $2.8M
Operating Income -$339M
Selling General And Administrative $100M
Research And Development $240M
Operating Expenses $337M
Investment Income Net -
Net Interest Income $41M
Interest Income $41M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.8M
Income Before Tax -$298M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$298M
Comprehensive Income Net Of Tax -
Ebit -$339M
Ebitda -$336M
Net Income -$298M

CRNX News

CRNX Profile

Crinetics Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Crinetics Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, dedicated to developing groundbreaking therapies for rare endocrine diseases and associated tumors. The company possesses a robust pipeline of innovative drug candidates, targeting significant unmet needs in the endocrine disorder market with both oral and targeted therapies. Crinetics is committed to advancing research and development efforts, positioning itself as a leader in specialized endocrine treatments, and striving to improve patient outcomes while transforming treatment paradigms in this vital healthcare sector.

LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
YCBD
+79.11%
$1.13
OCG
+210.71%
$2.83
CGC
+53.09%
$1.73
NVDA
-1.95%
$177.38
YGMZ
-61.42%
$0.02
PLUG
+3.38%
$2.44
RIVN
+13.29%
$18.61
WOK
-28.86%
$0.11
ASST
-3.79%
$0.88
ONDS
+4.03%
$9.38
KIND
+9.48%
$2.77
ATPC
-21.05%
$0.14
TSLA
+1.42%
$453.25
AVGO
-11.29%
$360.46
AXDX
-61.36%
$0.03
TLRY
+44.66%
$12.19
KAVL
-28.95%
$0.14
AKAN
+24.26%
$0.97
FRMI
-30.53%
$10.59
INTC
-3.49%
$38.13
TNYA
-35.26%
$0.88
ADAP
-15.14%
$0.05
TE
-9.70%
$5.30
ZDGE
+20.57%
$2.93
VIVK
-3.37%
$0.07
ORCL
-4.59%
$189.72
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
SOFI
+0.72%
$27.26
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
PLTD
+2.09%
$6.45
DNN
-5.06%
$2.62
F
+0.69%
$13.72
RR
-9.54%
$4.23
SRM
+53.27%
$10.30
PFE
-0.01%
$25.79
BMNR
-6.10%
$36.03
BMNU
-12.72%
$8.92
AAL
+1.07%
$15.12
PLTR
-2.10%
$183.60
BYND
-4.23%
$1.13
APLT
-45.50%
$0.11
ACHR
-1.18%
$8.45
WULF
-6.79%
$14.75
NFLX
+1.72%
$95.71
MARA
-0.67%
$11.75
ASBP
-8.42%
$0.09
CRWV
-8.43%
$80.00
IRBT
-10.63%
$4.46
BITF
-4.59%
$2.80
IREN
-4.60%
$41.91
MTSR
-0.35%
$70.50
KVUE
-0.02%
$17.31
FI
+2.38%
$68.16
AMD
-4.28%
$211.94
QBTS
-2.99%
$27.14
VALE
-4.55%
$12.68
CIFR
-5.34%
$17.87
BTG
-1.07%
$4.62
RKLB
+1.11%
$64.24
BAC
+0.97%
$55.09
AFMD
-34.94%
$0.18
IVP
-9.22%
$0.04
WBD
+1.40%
$29.90
GOOGL
-0.92%
$309.53
RZLT
+9.32%
$1.53
SOUN
-1.15%
$11.89
ABEV
+2.00%
$2.55
CLSK
-2.64%
$14.42
AAPL
-0.05%
$277.88
TWOH
0.00%
$0.00
AMZN
-1.43%
$226.98
SMR
-10.22%
$19.05
T
+0.96%
$24.53
KPLT
+18.77%
$7.36
CHR
-1.45%
$0.04
NOK
-1.48%
$6.26
HOOD
-2.10%
$120.78
GRYP
-10.38%
$1.38
SNAP
-1.89%
$7.49
CAN
-6.61%
$0.86
GRAB
+0.57%
$5.21
BBD
+1.31%
$3.45
MODV
-25.22%
$0.43
HPE
-2.42%
$23.94
NIO
0.00%
$5.13
RIG
-2.10%
$4.19
DVLT
0.00%
$1.44
CMG
+3.87%
$36.22
MU
-4.48%
$246.88
APLD
-2.08%
$30.12
HL
-3.85%
$18.60
NXDR
-9.11%
$2.51
AG
-6.39%
$15.73
IBRX
+11.41%
$2.44
CDE
-2.64%
$17.01
GPUS
-3.94%
$0.27
LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
YCBD
+79.11%
$1.13
OCG
+210.71%
$2.83
CGC
+53.09%
$1.73
NVDA
-1.95%
$177.38
YGMZ
-61.42%
$0.02
PLUG
+3.38%
$2.44
RIVN
+13.29%
$18.61
WOK
-28.86%
$0.11
ASST
-3.79%
$0.88
ONDS
+4.03%
$9.38
KIND
+9.48%
$2.77
ATPC
-21.05%
$0.14
TSLA
+1.42%
$453.25
AVGO
-11.29%
$360.46
AXDX
-61.36%
$0.03
TLRY
+44.66%
$12.19
KAVL
-28.95%
$0.14
AKAN
+24.26%
$0.97
FRMI
-30.53%
$10.59
INTC
-3.49%
$38.13
TNYA
-35.26%
$0.88
ADAP
-15.14%
$0.05
TE
-9.70%
$5.30
ZDGE
+20.57%
$2.93
VIVK
-3.37%
$0.07
ORCL
-4.59%
$189.72
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
SOFI
+0.72%
$27.26
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
PLTD
+2.09%
$6.45
DNN
-5.06%
$2.62
F
+0.69%
$13.72
RR
-9.54%
$4.23
SRM
+53.27%
$10.30
PFE
-0.01%
$25.79
BMNR
-6.10%
$36.03
BMNU
-12.72%
$8.92
AAL
+1.07%
$15.12
PLTR
-2.10%
$183.60
BYND
-4.23%
$1.13
APLT
-45.50%
$0.11
ACHR
-1.18%
$8.45
WULF
-6.79%
$14.75
NFLX
+1.72%
$95.71
MARA
-0.67%
$11.75
ASBP
-8.42%
$0.09
CRWV
-8.43%
$80.00
IRBT
-10.63%
$4.46
BITF
-4.59%
$2.80
IREN
-4.60%
$41.91
MTSR
-0.35%
$70.50
KVUE
-0.02%
$17.31
FI
+2.38%
$68.16
AMD
-4.28%
$211.94
QBTS
-2.99%
$27.14
VALE
-4.55%
$12.68
CIFR
-5.34%
$17.87
BTG
-1.07%
$4.62
RKLB
+1.11%
$64.24
BAC
+0.97%
$55.09
AFMD
-34.94%
$0.18
IVP
-9.22%
$0.04
WBD
+1.40%
$29.90
GOOGL
-0.92%
$309.53
RZLT
+9.32%
$1.53
SOUN
-1.15%
$11.89
ABEV
+2.00%
$2.55
CLSK
-2.64%
$14.42
AAPL
-0.05%
$277.88
TWOH
0.00%
$0.00
AMZN
-1.43%
$226.98
SMR
-10.22%
$19.05
T
+0.96%
$24.53
KPLT
+18.77%
$7.36
CHR
-1.45%
$0.04
NOK
-1.48%
$6.26
HOOD
-2.10%
$120.78
GRYP
-10.38%
$1.38
SNAP
-1.89%
$7.49
CAN
-6.61%
$0.86
GRAB
+0.57%
$5.21
BBD
+1.31%
$3.45
MODV
-25.22%
$0.43
HPE
-2.42%
$23.94
NIO
0.00%
$5.13
RIG
-2.10%
$4.19
DVLT
0.00%
$1.44
CMG
+3.87%
$36.22
MU
-4.48%
$246.88
APLD
-2.08%
$30.12
HL
-3.85%
$18.60
NXDR
-9.11%
$2.51
AG
-6.39%
$15.73
IBRX
+11.41%
$2.44
CDE
-2.64%
$17.01
GPUS
-3.94%
$0.27
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.